Még nem toboroz
Analysis of histological risk factors and biomarkers in paediatric retinoblastoma
2024-515962-15-00· 2. fázis· Institut Curie· Forrás
Toboroz
A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
NCT07444450· 3. fázis· Biogen· Forrás
Még nem toboroz
Phase I/II trial of Dinutuximab beta in combination with Irinotecan and Rapamycin in pediatric, adolescents and adult patients with relapsed/refractory bone tumors. BONE DINIRRA
2026-525463-40-00· 1/2. fázis· Les Hopitaux Universitaires De Strasbourg· Forrás
Toboroz
A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
2022-502365-26-00· 3. fázis· Novartis Pharma AG· Forrás
Toboroz
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
NCT07058077· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
NCT07334301· 1/2. fázis· University of Birmingham· Forrás
Fut, nem toboroz
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
2023-507655-30-00· 3. fázis· Eli Lilly & Co.· Forrás
Fut, nem toboroz
STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
NCT06571383· 4. fázis· Novo Nordisk A/S· Forrás
Még nem toboroz
Stopping Pneumonia Antibiotherapy Regimen Early
NCT06291012· 4. fázis· University Hospital, Montpellier· Forrás
Toboroz
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
NCT05835310· 3. fázis· AstraZeneca· Forrás
Toboroz
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
NCT05748171· 2. fázis· Pfizer· Forrás
Fut, nem toboroz
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
NCT05335876· 3. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
NCT05183035· 3. fázis· PedAL BCU, LLC· Forrás
Toboroz
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
NCT05476939· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás
Fut, nem toboroz
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
NCT05330325· 3. fázis· Novo Nordisk A/S· Forrás
Toboroz
A phase 2/3, multicenter, randomized, double-blind study to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of oral ozanimod (RPC1063) in pediatric subjects with moderately to severely active ulcerative colitis with an inadequate response to conventional therapy.
2023-509248-86-00· 2/3. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás
Toboroz
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
NCT05156398· 3. fázis· Pfizer· Forrás
Toboroz
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
2022-501454-11-00· 3. fázis· GPOH gGmbH· Forrás
Toboroz
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás
Fut, nem toboroz
A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy
NCT04015141· 2. fázis· Eisai Inc.· Forrás
Fut, nem toboroz
Phase II trial of nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma, for evaluation of response in patients with progressive disease (Cohort 1) or as consolidative immunotherapy in patients in complete remission after relapse (Cohort 2) - NIVO ALCL
2024-516807-17-00· 2. fázis· Institut Gustave Roussy· Forrás
Fut, nem toboroz
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
NCT03793478· 1/2. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension
NCT03492177· 2. fázis· Actelion· Forrás
Toboroz
Inotuzumab ozogamicin for Acute Lymphoblastic Leukemia
2023-504694-20-00· 1/2. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás
Toboroz
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
2024-516078-31-00· 2/3. fázis· The University Of Birmingham· Forrás
Fut, nem toboroz
Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma
NCT00470223· 3. fázis· UNICANCER· Forrás